Archives - October 09, 2020

	Government says no to Russia's Sputnik corona vaccine trial in India Problem for Dr Reddy as Indian Govt refuses Russian sputnik vaccine trial in the country... Oct 09
	China formally joins WHO led COVAX initiative on COVID-19 vaccine The COVAX facility, led by the World Health Organization, aims to deliver at least 2 billion doses of vaccines by the end of 2021 ... Oct 09
	Bangladesh to accept only WHO recognised COVID-19 Vaccine Bangladesh Government has been in touch with all the countries and organisations trying to develop the vaccine.... Oct 09
	Y-mAbs’ Nivatrotamab granted Orphan Drug Designation and Rare Pediatric Disease designation by FDA Researchers at Memorial Sloan Kettering Cancer Center developed nivatrotamab, which is exclusively licensed by MSK to Y-mAbs... Oct 09
	Tianda Pharmaceuticals acquires Yeung & Young Medicare and Qi's Living The acquisition and cooperation represent an important step for the Group in the development of the entire TCM industrial chain... Oct 09
	Maharashtra’s 2nd successful small intestine transplant done at Jupiter hospital, Pune It is the only hospital in Maharashtra that has successfully performed small intestinal transplants so far... Oct 09
	Rapid bedside testing is faster than standard centralised PCR testing for COVID-19 Rapid testing of suspected cases of COVID-19 will be key to containment and preventing hospitals from becoming overwhelmed... Oct 09
	GSK's Dovato holds against Tenofavir Alafenamide Fumarate for HIV1 patients GSK two drug combination is as good as 3 drug regimen which is presently continued for HIV 1 patients... Oct 09
	Pfizer reports weekly Somatrogon is more effective in human growth deficiency Clinical Study proves weekly administration of Somatrogon more effective in treating human growth deficiency disease... Oct 09
	Sobi announces topline phase 3 data of avatrombopag for the treatment of Chemotherapy ... Oct 09
	Johnson & Johnson receives approval from European Commission to provide 200 million doses of COVID-19 vaccine This contract comes after the conclusion of exploratory talks with the European Commission... Oct 09
	PENELOPE-B TRIAL OF IBRANCE (PALBOCICLIB) IN EARLY BREAST CANCER DID NOT MEET PRIMARY ENDPOINT We are proud of the transformative impact IBRANCE has had on the treatment of HR+, HER2- metastatic breast cancer... Oct 09
	PENELOPE-B TRIAL OF IBRANCE (PALBOCICLIB) IN EARLY BREAST CANCER DID NOT MEET PRIMARY ENDPOINT We are proud of the transformative impact IBRANCE has had on the treatment of HR+, HER2- metastatic breast cancer... Oct 09
	Several eminent persons in Assam join Jan Andolan for COVID-19 Appropriate Behaviour In Assam, several eminent persons have joined the Jan Andolan for COVID-19 Appropriate Behaviour in view of the upcoming festivals and the winter season ... Oct 09
	Nepal’s COVID-19 cases cross one lakh mark The Kathmandu Valley has emerged as a hotspot for COVID-19 virus and recorded 1409 new cases. The Ministry of Health and Population has asked ... Oct 09
	MCGM, Google collaborate to mark Containment Zones in Mumbai on Google Maps In a unique association, the Municipal Corporation of Greater Mumbai (MCGM) and Google have collaborated to mark Containment Zones in the city on the Google ... Oct 09
	Leading a family-run 30 bed hospital business to leading a marketing team of 350 bedded Aster DM Healthcare across 8 countries - Meet Vivek Shukla, Partner Healthcare, RSM Healthcare AE ... Oct 09
	MCGM, Google collaborate to mark Containment Zones in Mumbai on Google Maps In a unique association, the Municipal Corporation of Greater Mumbai (MCGM) and Google have collaborated to mark Containment Zones in the city on the Google ... Oct 09
	Innovent and Eli Lilly announce the NMPA granted marketing approval for HALPRYZA in China The survival rate is also relatively higher than other tumour types when having appropriate treatment... Oct 09
	COVID-19 AntiBody (LAAB) combination AZD7442 rapidly advances into Phase III clinical trials The combination of two LAABs is also designed to reduce the risk of resistance developed by the SARS-CoV-2 virus.... Oct 09
	COVID-19 AntiBody (LAAB) combination AZD7442 rapidly advances into Phase III clinical trials The combination of two LAABs is also designed to reduce the risk of resistance developed by the SARS-CoV-2 virus.... Oct 09
21 Stories found!